Skip to main content

Table 3 Data concerning infections in the patients studied during the five year study period

From: Predictors of response and drug survival in ankylosing spondylitis patients treated with infliximab

Most frequently reported infections in 5 years study population (n = 70 patients) N (%)
Upper respiratory tract infections (rhinosinusitis, pharyngitis, laryngitis, colds) 13 (18.6 %)
Bronchitis/bronchopneumonia 6 (8.6 %)
Conjunctivitis eye disorders 5 (7.1 %)
Influenza episodes 4 (5.7 %)
Diarrhea 4 (5.7 %)
Urinary infections 4 (5.7 %)
Otitis 2 (2.8 %)
Severe skin infections 2 (2.8 %)
Dental infections 2 (2.8 %)
Vaginitis 1 (1.4 %)
Herpes labialis 1 (1.4 %)
Tubal ascess 1 (1.4 %)